92134

Scanning computerized ophthalmic diagnostic imaging, posterior segment, with interpretation and report, unilateral or bilateral; retina

CPT code 92134 represents the utilization of scanning computerized ophthalmic diagnostic imaging, specifically focusing on the posterior segment to evaluate the retina. This highly advanced, non-invasive imaging technique predominantly utilizes Optical Coherence Tomography (OCT) to capture high-resolution, cross-sectional, and three-dimensional images of the retinal layers. By employing near-infrared light interferometry, the technology detects and measures the echo time delay and magnitude of backscattered light from the distinct microscopic layers of the retina. This allows for precise, micrometer-level quantitative analysis of retinal thickness and qualitative assessment of morphological changes, such as intraretinal fluid, subretinal fluid, drusen, pigment epithelial detachments, and disruptions in the photoreceptor layers. The procedure is paramount in the modern diagnosis, management, and longitudinal monitoring of a wide array of retinal pathologies. These include age-related macular degeneration (both dry and wet forms), diabetic retinopathy, diabetic macular edema, macular holes, epiretinal membranes, central serous chorioretinopathy, and retinal vascular occlusions. Furthermore, it is a critical tool for monitoring potential retinal toxicity from systemic medications, such as hydroxychloroquine. The service inherently includes both the technical acquisition of the images and the professional interpretation and report by the physician. It is defined as a unilateral or bilateral code, meaning the same code applies regardless of whether one or both eyes are imaged during the encounter. A formal, detailed report documenting the findings, comparing them to prior studies if available, and outlining the clinical implications must be maintained in the patient's medical record to support the billing of this code. Additionally, the integration of this scanning computerized ophthalmic diagnostic imaging into routine ophthalmic practice has revolutionized therapeutic paradigms, particularly regarding the administration of intravitreal anti-vascular endothelial growth factor injections. By providing objective metrics on central macular thickness and the presence of fluid compartments, the imaging directly guides retreatment decisions, ensuring optimal visual outcomes while minimizing unnecessary interventions. The physician's interpretation must synthesize the quantitative data with the patient's visual symptoms and clinical exam findings to formulate a comprehensive management plan. Documentation must clearly reflect the medical necessity for the scan on the specific date of service.

Clinical Indications

  • Age-related macular degeneration (AMD), including exudative (wet) and nonexudative (dry) forms.
  • Diabetic retinopathy and associated diabetic macular edema (DME).
  • Epiretinal membrane (macular pucker) and vitreomacular traction syndrome.
  • Macular holes (full-thickness, lamellar, or impending).
  • Central serous chorioretinopathy.
  • Retinal vascular occlusions, including central and branch retinal vein or artery occlusions.
  • Monitoring for retinal toxicity from long-term use of systemic medications (e.g., hydroxychloroquine, pentosan polysulfate).
  • Unexplained visual loss suspected to be of retinal or macular origin.

Procedure Steps

  1. Review the patient's medical history, current visual symptoms, and prior imaging to confirm the medical necessity for retinal imaging.
  2. Explain the non-invasive nature of the Optical Coherence Tomography (OCT) procedure to the patient.
  3. Administer dilating drops if medically necessary for optimal visualization, although modern OCT devices can often capture high-quality images through an undilated pupil.
  4. Seat the patient comfortably at the scanning computerized ophthalmic diagnostic imaging device, ensuring proper head positioning in the chin rest and forehead strap.
  5. Instruct the patient to focus on an internal fixation target to stabilize the eye and center the scanning beam directly on the macula.
  6. Acquire high-resolution, cross-sectional, and volumetric scans of the posterior segment, specifically targeting the retina and macula of the affected eye or eyes.
  7. Review the acquired images in real-time to verify adequate signal strength, correct centration, and the absence of motion artifacts or blink artifacts.
  8. Perform quantitative analysis using the device's integrated software to measure macular thickness and map specific structural changes across the retinal grid.
  9. Physician interprets the morphological findings, analyzing the presence of intraretinal fluid, subretinal fluid, drusen, or structural architectural distortion.
  10. Generate and sign a formal written report documenting the clinical findings, comparative analysis with prior scans, and the direct impact on the ongoing clinical management plan.

Coding Guidelines

  • CPT code 92134 is defined as unilateral or bilateral; do not append modifier 50 (Bilateral procedure) or RT/LT modifiers to indicate laterality for payment purposes, as reimbursement is identical whether one or both eyes are imaged.
  • Do not report 92134 in conjunction with CPT code 92133 (Scanning computerized ophthalmic diagnostic imaging, optic nerve) on the same day for the same patient. NCCI edits bundle these codes because they are mutually exclusive on the same date of service, unless distinct, separately identifiable pathology justifies imaging both structures, which may require an appropriate modifier depending on payer policy.
  • A distinct, written interpretation and report must be documented in the patient's medical record; a simple printout of the images generated by the machine is insufficient to bill the global code or professional component.
  • If only the technical component of the procedure is performed (e.g., at an independent testing facility), append modifier TC. If only the professional component is performed (e.g., physician interpreting images captured elsewhere), append modifier 26. Reporting the code without a modifier implies the complete global service was provided.
  • Medical necessity must be clearly supported by the primary ICD-10 diagnosis code; routine screening without signs, symptoms, or known pathology is generally not covered by Medicare or most commercial payers.